THE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF DEPRESSION - CURRENT STATE OF KNOWLEDGE
Abstract
In recent years, there has been growing interest in the role of the gut microbiome in modulating brain function and its potential impact on mental disorders, including depression. The gut-brain axis, a complex communication network between the gastrointestinal tract and the central nervous system, is crucial for comprehending the relationship between gut microbiota and mental health. Communication along this pathway takes place through various pathways: neuronal, hormonal, and immunological. Multiple preclinical and clinical investigations demonstrate that alterations in the composition and diversity of gut microbiota can influence neuroinflammatory mechanisms, neurotransmitter metabolism, and hypothalamic-pituitary-adrenal (HPA) axis function, potentially facilitating the emergence of depressive symptoms. This article aims to examine contemporary findings about the mechanisms by which the gut microbiome affects mood and to evaluate potential treatment strategies, including psychobiotics, dietary modifications, and fecal microbiota transplantation. Comprehending the function of the microbiome in the etiology of depression could provide novel avenues for the diagnosis and treatment of affective disorders. Although the current state of knowledge does not yet allow the formulation of concrete conclusions and diagnostic and therapeutic recommendations, it certainly encourages further research.
References
Rost F, Booker T, Gonsard A, de Felice G, Asseburg L, Malda-Castillo J, et al. The complexity of treatment-resistant depression: A data-driven approach. J Affect Disord 2024;358:292–301. https://doi.org/10.1016/j.jad.2024.04.093.
Shi L, Ren J, Jin K, Li J. Depression and risk of infectious diseases: A mendelian randomization study. Transl Psychiatry 2024;14. https://doi.org/10.1038/s41398-024-02950-8.
De Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022;71:1020–32. https://doi.org/10.1136/gutjnl-2021-326789.
Tao J, Li S, Gan R-Y, Zhao C-N, Meng X, Li H-B. Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. Crit Rev Food Sci Nutr 2020;60:1025–37. https://doi.org/10.1080/10408398.2018.1555789.
Riva A, Kuzyk O, Forsberg E, Siuzdak G, Pfann C, Herbold C, et al. A fiber-deprived diet disturbs the fine-scale spatial architecture of the murine colon microbiome. Nat Commun 2019;10. https://doi.org/10.1038/s41467-019-12413-0.
Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut 2019;68:1417–29. https://doi.org/10.1136/gutjnl-2018-317609.
Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut 2020;69:1510–9. https://doi.org/10.1136/gutjnl-2019-320204.
Bradley E, Haran J. The human gut microbiome and aging. Gut Microbes 2024;16. https://doi.org/10.1080/19490976.2024.2359677.
Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease. Physiol Rev 2020;100:171–210. https://doi.org/10.1152/physrev.00041.2018.
DeMartino P, Cockburn DW. Resistant starch: impact on the gut microbiome and health. Curr OpinBiotechnol 2020;61:66–71. https://doi.org/10.1016/j.copbio.2019.10.008.
Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 2018;57. https://doi.org/10.1007/s00394-017-1445-8.
Bhutta NK, Xu X, Jian C, Wang Y, Liu Y, Sun J, et al. Gut microbiota mediated T cells regulation and autoimmune diseases. Front Microbiol 2024;15:1477187. https://doi.org/10.3389/fmicb.2024.1477187.
Saeed NK, Al-Beltagi M, Bediwy AS, El-Sawaf Y, Toema O. Gut microbiota in various childhood disorders: Implication and indications. World J Gastroenterol 2022;28:1875–901. https://doi.org/10.3748/wjg.v28.i18.1875.
O’Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF. The gut microbiota-immune-brain axis: Therapeutic implications. Cell Rep Med 2025:101982. https://doi.org/10.1016/j.xcrm.2025.101982.
Tang Y, Zhang Y, Chen C, Cao Y, Wang Q, Tang C. Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease. J Cent NervSyst Dis 2025;17. https://doi.org/10.1177/11795735251322450.
Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of Intestinal Barrier Function by Microbial Metabolites. CMGH 2021;11:1463–82. https://doi.org/10.1016/j.jcmgh.2021.02.007.
Młynarska E, Gadzinowska J, Tokarek J, Forycka J, Szuman A, Franczyk B, et al. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder. Nutrients 2022;14. https://doi.org/10.3390/nu14091921.
Kronsten VT, Tranah TH, Pariante C, Shawcross DL. Gut-derived systemic inflammation as a driver of depression in chronic liver disease. J Hepatol 2022;76:665–80. https://doi.org/10.1016/j.jhep.2021.11.008.
Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine 2023;90. https://doi.org/10.1016/j.ebiom.2023.104527.
Alli SR, Gorbovskaya I, Liu JCW, Kolla NJ, Brown L, Müller DJ. The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies. Int J Mol Sci 2022;23. https://doi.org/10.3390/ijms23094494.
Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics 2018;15:36–59. https://doi.org/10.1007/s13311-017-0585-0.
Bear TLK, Dalziel JE, Coad J, Roy NC, Butts CA, Gopal PK. The role of the gut microbiota in dietary interventions for depression and anxiety. Advances in Nutrition 2020;11:890–907. https://doi.org/10.1093/advances/nmaa016.
Song J, Zhou B, Kan J, Liu G, Zhang S, Si L, et al. Gut microbiota: Linking nutrition and perinatal depression. Front Cell Infect Microbiol 2022;12. https://doi.org/10.3389/fcimb.2022.932309.
Xiong RG, Li J, Cheng J, Zhou DD, Wu SX, Huang SY, et al. The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components. Nutrients 2023;15. https://doi.org/10.3390/nu15143258.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506–14. https://doi.org/10.1038/nrgastro.2014.66.
Ballini A, Charitos IA, Cantore S, Topi S, Bottalico L, Santacroce L. About Functional Foods: The Probiotics and Prebiotics State of Art. Antibiotics 2023;12. https://doi.org/10.3390/antibiotics12040635.
Bhutto RA, Bhutto N ul ain H, Mahar H, Khanal S, Wang M, Iqbal S, et al. Recent trends in co-encapsulation of probiotics with prebiotics and their applications in the food industry. Trends Food Sci Technol 2025;156. https://doi.org/10.1016/j.tifs.2024.104829.
Zhu R, Fang Y, Li H, Liu Y, Wei J, Zhang S, et al. Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism. Front Immunol 2023;14. https://doi.org/10.3389/fimmu.2023.1158137.
Bankah AZ, Tagoe TA, Darko E, Agoha R, Ametefe EN, Kukuia KKE, et al. Combined Administration of Lactobacillus or Bifidobacterium Offers Enhanced Antidepressant and Anxiolytic Activity in a Dose Dependent Manner. Brain Behav 2025;15. https://doi.org/10.1002/brb3.70564.
Tillmann S, Awwad HM, Eskelund AR, Treccani G, Geisel J, Wegener G, et al. Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression. Mol Nutr Food Res 2018;62. https://doi.org/10.1002/mnfr.201701070.
Leeuwendaal NK, Stanton C, O’toole PW, Beresford TP. Fermented Foods, Health and the Gut Microbiome. Nutrients 2022;14. https://doi.org/10.3390/nu14071527.
Yoo S, Jung SC, Kwak K, Kim JS. The Role of Prebiotics in Modulating Gut Microbiota: Implications for Human Health. Int J Mol Sci 2024;25. https://doi.org/10.3390/ijms25094834.
Zhang Q, Bi Y, Zhang B, Jiang Q, Mou CK, Lei L, et al. Current landscape of fecal microbiota transplantation in treating depression. Front Immunol 2024;15. https://doi.org/10.3389/fimmu.2024.1416961.
Hu B, Das P, Lv X, Shi M, Aa J, Wang K, et al. Effects of ‘Healthy’ Fecal Microbiota Transplantation against the Deterioration of Depression in Fawn-Hooded Rats. MSystems 2022;7. https://doi.org/10.1128/msystems.00218-22.
Kim KO, Gluck M. Fecal microbiota transplantation: An update on clinical practice. Clin Endosc 2019;52:137–43. https://doi.org/10.5946/CE.2019.009.
Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep 2020;10. https://doi.org/10.1038/s41598-020-74934-9.
Shen Y, Yang X, Li G, Gao J, Liang Y. The change of gut microbiota in MDD patients under SSRIs treatment. Sci Rep 2021;11. https://doi.org/10.1038/s41598-021-94481-1.
Duan J, Huang Y, Tan X, Chai T, Wu J, Zhang H, et al. Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment. Transl Psychiatry 2021;11. https://doi.org/10.1038/s41398-021-01428-1.
Diviccaro S, Giatti S, Cioffi L, Falvo E, Piazza R, Caruso D, et al. Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and microbiota. Psychoneuroendocrinology 2022;143. https://doi.org/10.1016/j.psyneuen.2022.105828.
Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 2020;11. https://doi.org/10.1038/s41467-019-14177-z.
Klünemann M, Andrejev S, Blasche S, Mateus A, Phapale P, Devendran S, et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 2021;597:533–8. https://doi.org/10.1038/s41586-021-03891-8.
Jiang R, Wang Y, Liu J, Wu Z, Wang D, Deng Q, et al. Gut microbiota is involved in the antidepressant effects of adipose-derived mesenchymal stem cells in chronic social defeat stress mouse model. Psychopharmacology (Berl) 2022;239:533–49. https://doi.org/10.1007/s00213-021-06037-w.
Lee SM, Dong TS, Krause-Sorio B, Siddarth P, Milillo MM, Lagishetty V, et al. The intestinal microbiota as a predictor for antidepressant treatment outcome in geriatric depression: A prospective pilot study. Int Psychogeriatr 2022;34:33–45. https://doi.org/10.1017/S1041610221000120.
Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res 2018;1693:128–33. https://doi.org/10.1016/j.brainres.2018.03.015.
Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019;4:623–32. https://doi.org/10.1038/s41564-018-0337-x.
Views:
249
Downloads:
226
Copyright (c) 2025 Agnieszka Zaleszczyk, Katarzyna Oświeczyńska, Agnieszka Kasprzak, Patrycja Jędrzejewska-Rzezak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
